RANK rs1805034 T>C polymorphism is associated with susceptibility of esophageal cancer in a Chinese population

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Yin, Jun ^a   Wang, Liming ^a   Tang, Weifeng ^a   Wang, Xu ^a   Lv, Lu ^a   Shao, Aizhong ^a   Shi, Yijun ^a   Ding, Guowen ^a   Chen, Suocheng ^a   Gu, Haiyong ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MICRORNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPG GENE; RANK GENE; RANKL GENE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SQUAMOUS CELL CARCINOMA;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 84904252967     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101705     Document Type: Article

References (50)

1. Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013) Oesophageal carcinoma. Lancet. 381:400-412
2. Enzinger PC, Mayer RJ (2003) Esophageal cancer. The New England journal of medicine. 349:2241-2252 (Pubitemid 37485141)
3. Chen W, He Y, Zheng R, Zhang S, Zeng H, et al. (2013) Esophageal cancer incidence and mortality in china, 2009. Journal of thoracic disease.5:19-26
4. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, et al. (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. Journal of the National Cancer Institute. 89:1277-1284 (Pubitemid 27371948)
5. De Stefani E, Barrios E, Fierro L (1993) Black (air-cured) and blond (flue-cured) tobacco and cancer risk. Iii: Oesophageal cancer. European journal of cancer. 29A:763-766 (Pubitemid 23077062)
6. Lee CH, Wu DC, Lee JM, Wu IC, Goan YG, et al. (2007) Carcinogenetic impact of alcohol intake on squamous cell carcinoma risk of the oesophagus in relation to tobacco smoking. European journal of cancer. 43:1188-1199 (Pubitemid 46590738)
7. Brown LM, Hoover R, Silverman D, Baris D, Hayes R, et al. (2001) Excess incidence of squamous cell esophageal cancer among us black men: Role of social class and other risk factors. American journal of epidemiology. 153:114-122 (Pubitemid 32063186)
8. Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, et al. (2003) Prospective study of serum vitamin e levels and esophageal and gastric cancers. Journal of the National Cancer Institute. 95:1414-1416 (Pubitemid 37220461)
9. Abnet CC, Lai B, Qiao YL, Vogt S, Luo XM, et al. (2005) Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. Journal of the National Cancer Institute. 97:301-306 (Pubitemid 40310278)
10. Ney JT, Juhasz-Boess I, Gruenhage F, Graeber S, Bohle RM, et al. (2013) Genetic polymorphism of the opg gene associated with breast cancer. BMC cancer. 13:40
11. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, et al. (1997) Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 89:309-319 (Pubitemid 27199902)
12. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165-176 (Pubitemid 28180851)
13. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, et al. (1997) A homologue of the tnf receptor and its ligand enhance t-cell growth and dendritic-cell function. Nature. 390:175-179 (Pubitemid 27507987)
14. Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, et al. (2012) Bench to bedside: Elucidation of the opg-rank-rankl pathway and the development of denosumab. Nature reviews. Drug discovery. 11:401-419
15. Brown JM, Corey E, Lee ZD, True LD, Yun TJ, et al. (2001) Osteoprotegerin and rank ligand expression in prostate cancer. Urology. 57:611-616
16. Giuliani N, Colla S, Sala R, Moroni M, Lazzaretti M, et al. (2002) Human myeloma cells stimulate the receptor activator of nuclear factor-kappa b ligand (rankl) in t lymphocytes: A potential role in multiple myeloma bone disease. Blood. 100:4615-4621 (Pubitemid 35429706)
17. Zhang J, Dai J, Qi Y, Lin DL, Smith P, et al. (2001) Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. The Journal of clinical investigation. 107:1235-1244 (Pubitemid 32494540)
18. Good CR, O'Keefe RJ, Puzas JE, Schwarz EM, Rosier RN (2002) Immunohistochemical study of receptor activator of nuclear factor kappa-b ligand (rank-l) in human osteolytic bone tumors. Journal of surgical oncology. 79:174-179
19. Huang L, Cheng YY, Chow LT, Zheng MH, Kumta SM (2002) Tumour cells produce receptor activator of nf-kappab ligand (rankl) in skeletal metastases. Journal of clinical pathology. 55:877-878 (Pubitemid 35316262)
20. Quinn JE, Brown LG, Zhang J, Keller ET, Vessella RL, et al. (2005) Comparison of fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms. Prostate cancer and prostatic diseases. 8:253-259 (Pubitemid 43118063)
21. Whang PG, Schwarz EM, Gamradt SC, Dougall WC, Lieberman JR (2005) The effects of rank blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 23:1475-1483
22. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, et al. (2010) Control of mammary stem cell function by steroid hormone signalling. Nature. 465:798-802
23. Beleut M, Rajaram RD, Caikovski M, Ayyanan A, Germano D, et al. (2010) Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proceedings of the National Academy of Sciences of the United States of America. 107:2989-2994
24. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, et al. (2010) Progesterone induces adult mammary stem cell expansion. Nature. 465:803-807
25. Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, et al. (2010) Rank ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature. 468:103-107
26. Tan W, Zhang W, Strasner A, Grivennikov S, Cheng JQ, et al. (2011) Tumour-infiltrating regulatory t cells stimulate mammary cancer metastasis through rankl-rank signalling. Nature. 470:548-553
27. McGonigle JS, Giachelli CM, Scatena M (2009) Osteoprotegerin and rankl differentially regulate angiogenesis and endothelial cell function. Angiogenesis. 12:35-46
28. Fisher JL, Thomas-Mudge RJ, Elliott J, Hards DK, Sims NA, et al. (2006) Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically. Cancer research. 66:3620-3628
29. Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, et al. (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 28:5132-5139
30. Assmann G, Koenig J, Pfreundschuh M, Epplen JT, Kekow J, et al. (2010) Genetic variations in genes encoding rank, rankl, and opg in rheumatoid arthritis: A case-control study. The Journal of rheumatology. 37:900-904
31. Chung PY, Beyens G, Riches PL, Van Wesenbeeck L, de Freitas F, et al. (2010) Genetic variation in the tnfrsf11a gene encoding rank is associated with susceptibility to paget's disease of bone. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 25:2592-2605
32. Zhang YP, Liu YZ, Guo Y, Liu XG, Xu XH, et al. (2011) Pathway-based association analyses identified trail pathway for osteoporotic fractures. PloS one. 6:e21835
33. Yin J, Wang X, Zheng L, Shi Y, Wang L, et al. (2013) Hsa-mir-34b/c rs4938723 t>c and hsa-mir-423 rs6505162 c>a polymorphisms are associated with the risk of esophageal cancer in a chinese population. PloS one. 8:e80570
34. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, et al. (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nature genetics. 43:55-59
35. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, et al. (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & development. 12:1260-1268 (Pubitemid 28213402)
36. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, et al. (1989) The bone marrow-derived stromal cell lines mc3t3-g2/pa6 and st2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 125:1805-1813 (Pubitemid 19258613)
37. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, et al. (1997) Trance is a novel ligand of the tumor necrosis factor receptor family that activates c-jun n-terminal kinase in t cells. The Journal of biological chemistry. 272:25190-25194 (Pubitemid 27415705)
38. Jorgensen HL, Kusk P, Madsen B, Fenger M, Lauritzen JB (2004) Serum osteoprotegerin (opg) and the a163g polymorphism in the opg promoter region are related to peripheral measures of bone mass and fracture odds ratios. Journal of bone and mineral metabolism. 22:132-138 (Pubitemid 38405042)
39. Roshandel D, Holliday KL, Pye SR, Boonen S, Borghs H, et al. (2010) Genetic variation in the rankl/rank/opg signaling pathway is associated with bone turnover and bone mineral density in men. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 25:1830-1838
40. Hsu YH, Niu T, Terwedow HA, Xu X, Feng Y, et al. (2006) Variation in genes involved in the rankl/rank/opg bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Human genetics. 118:568-577 (Pubitemid 41825129)
41. Katz J, Gong Y, Salmasinia D, Hou W, Burkley B, et al. (2011) Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. International journal of oral and maxillofacial surgery. 40:605-611
42. Pitocco D, Zelano G, Gioffre G, Di Stasio E, Zaccardi F, et al. (2009) Association between osteoprotegerin g1181c and t245g polymorphisms and diabetic charcot neuroarthropathy: A case-control study. Diabetes care. 32:1694-1697
43. Huang CH, Wei JC, Hung PS, Shiu LJ, Tsay MD, et al. (2011) Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. Rheumatology. 50:359-365
44. Rhee EJ, Yun EJ, Oh KW, Park SE, Park CY, et al. (2010) The relationship between receptor activator of nuclear factor-kappab ligand (rankl) gene polymorphism and aortic calcification in korean women. Endocrine journal. 57:541-549
45. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 447:1087-1093 (Pubitemid 47014426)
46. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in fgfr2 associated with risk of sporadic postmenopausal breast cancer. Nature genetics. 39:870-874 (Pubitemid 47014500)
47. Bonifaci N, Palafox M, Pellegrini P, Osorio A, Benitez J, et al. (2011) Evidence for a link between tnfrsf11a and risk of breast cancer. Breast cancer research and treatment. 129:947-954
48. Chu LW, Meyer TE, Li Q, Menashe I, Yu K, et al. (2010) Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19:1848-1854
49. Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, et al. (2007) Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nature genetics. 39:989-994 (Pubitemid 47185183)
50. Feng XS, Yang YT, Gao SG, Ru Y, Wang GP, et al. (2014) Prevalence and age, gender and geographical area distribution of esophageal squamous cell carcinomas in north china from 1985 to 2006. Asian Pacific journal of cancer prevention: APJCP. 15:1981-1987